Skip to content
HowShorted

Oruka Therapeutics, Inc. short interest in 2018

In 2018, Oruka Therapeutics, Inc.'s disclosed short interest ran from 0.99% of shares outstanding on 12 Jan 2018 to 2.68% on 31 Dec 2018, a change of +1.69 percentage points. The year's high was 2.68% on 31 Dec 2018 and its low 0.30% on 15 Jun 2018, averaging 1.40% across 20 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 2.87 days on 14 Dec 2018. Full history: Oruka Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Oruka Therapeutics, Inc. in 2018

2018 in figures

Start of year
0.99% (12 Jan 2018)
End of year
2.68% (31 Dec 2018)
Change
+1.69 pp
High
2.68% (31 Dec 2018)
Low
0.30% (15 Jun 2018)
Average
1.40%
Highest days to cover
2.87 (14 Dec 2018)
SEC filings marked
9

Every report in 2018

Oruka Therapeutics, Inc. short interest in 2018
SettlementShort interestDays to coverFilings since previous
12 Jan 20180.99%1.00
31 Jan 20181.12%1.00
15 Feb 20180.84%1.00
28 Feb 20181.26%1.00results (8-K)
15 Mar 20180.83%1.00
29 Mar 20181.71%1.0010-K filed, results (8-K)
13 Apr 20181.49%1.00
30 Apr 20180.67%1.00
31 May 20180.62%1.0010-Q filed, results (8-K)
15 Jun 20180.30%1.00
15 Aug 20181.62%1.0010-Q filed, results (8-K)
31 Aug 20180.99%1.00
14 Sep 20180.96%1.00
28 Sep 20180.85%1.00
15 Oct 20181.96%1.00
31 Oct 20182.08%1.00
15 Nov 20182.31%1.0010-Q filed, results (8-K)
30 Nov 20182.27%2.31
14 Dec 20182.55%2.87
31 Dec 20182.68%1.63

See also: Oruka Therapeutics, Inc.'s full history · most shorted US stocks of 2018 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.